as 04-18-2025 1:31pm EST
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Upcoming Earnings Alert:
Get ready for potential market movements as Balchem Corporation BCPC prepares to release earnings report on 24 Apr 2025.
Founded: | 1967 | Country: | United States |
Employees: | N/A | City: | MONTVALE |
Market Cap: | 5.3B | IPO Year: | N/A |
Target Price: | $190.00 | AVG Volume (30 days): | 231.1K |
Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
Dividend Yield: | Dividend Payout Frequency: | Annual | |
EPS: | 3.93 | EPS Growth: | 17.31 |
52 Week Low/High: | $137.69 - $186.03 | Next Earning Date: | 04-24-2025 |
Revenue: | $953,684,000 | Revenue Growth: | 3.39% |
Revenue Growth (this year): | 8.63% | Revenue Growth (next year): | 8.59% |
BCPC Breaking Stock News: Dive into BCPC Ticker-Specific Updates for Smart Investing
Argus Research
3 days ago
GlobeNewswire
8 days ago
Argus Research
10 days ago
Argus Research
17 days ago
Argus Research
24 days ago
Simply Wall St.
a month ago
Argus Research
a month ago
Argus Research
2 months ago
The information presented on this page, "BCPC Balchem Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.